Banque Cantonale Vaudoise Gilead Sciences, Inc. Transaction History

Banque Cantonale Vaudoise

$2.52 Billion
Q2 2024

A detailed history of Banque Cantonale Vaudoise transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 148,331 shares of GILD stock, worth $12.4 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

148,331

Previous 127,866 16.01%

Holding current value

$12.4 Million

Previous $9.37 Million 8.67%

% of portfolio

0.4%

Previous 0.37%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$63.15 - $72.88 $1.29 Million - $1.49 Million	20,465 Added 16.01%	148,331 $10.2 Million
Q1 2024 Apr 10, 2024	BUY	$71.58 - $87.29 $1.36 Million - $1.66 Million	19,030 Added 17.49%	127,866 $9.37 Million
Q4 2023 Feb 07, 2024	BUY	$73.27 - $83.09 $420,056 - $476,354	5,733 Added 5.56%	108,836 $8.82 Million
Q3 2023 Nov 08, 2023	SELL	$73.94 - $80.67 $1.12 Million - $1.22 Million	-15,099 Reduced 12.77%	103,103 $7.73 Million
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $2.02 Million - $2.3 Million	-26,530 Reduced 18.33%	118,202 $9.11 Million
Q1 2023 Apr 20, 2023	BUY	$77.31 - $88.08 $275,610 - $314,005	3,565 Added 2.53%	144,732 $12 Million
Q4 2022 Feb 10, 2023	BUY	$62.32 - $89.47 $921,338 - $1.32 Million	14,784 Added 11.7%	141,167 $12.1 Million
Q3 2022 Oct 17, 2022	SELL	$59.54 - $68.01 $148,611 - $169,752	-2,496 Reduced 1.94%	126,383 $7.8 Million
Q2 2022 Aug 02, 2022	SELL	$57.72 - $65.01 $428,917 - $483,089	-7,431 Reduced 5.45%	128,879 $7.97 Million
Q1 2022 May 09, 2022	BUY	$57.92 - $72.58 $624,088 - $782,049	10,775 Added 8.58%	136,310 $8.1 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $225,068 - $255,457	3,469 Added 2.84%	125,535 $9.11 Million
Q3 2021 Oct 29, 2021	SELL	$67.69 - $73.03 $279,559 - $301,613	-4,130 Reduced 3.27%	122,066 $8.53 Million
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $301,482 - $329,412	-4,750 Reduced 3.63%	126,196 $8.69 Million
Q1 2021 May 11, 2021	BUY	$60.0 - $68.46 $90,300 - $103,032	1,505 Added 1.16%	130,946 $8.46 Million
Q4 2020 Feb 05, 2021	BUY	$56.65 - $64.55 $396,889 - $452,237	7,006 Added 5.72%	129,441 $7.54 Million
Q3 2020 Oct 30, 2020	BUY	$62.1 - $78.08 $1.82 Million - $2.29 Million	29,290 Added 31.45%	122,435 $7.74 Million
Q2 2020 Jul 22, 2020	SELL	$72.34 - $84.0 $520,703 - $604,632	-7,198 Reduced 7.17%	93,145 $7.17 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $151,689 - $194,292	2,422 Added 2.47%	100,343 $7.5 Million
Q4 2019 Feb 10, 2020	BUY	$61.62 - $67.78 $6.03 Million - $6.64 Million	97,921 New	97,921 $6.37 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Account

Banque Cantonale Vaudoise Gilead Sciences, Inc. Transaction History